Palleon Pharma
@Palleon_Pharma
Clinical-stage biotechnology company developing drugs that harness glyco-immunology to treat cancer and inflammatory diseases
ID:893502827615711233
http://palleonpharma.com/ 04-08-2017 16:04:09
809 Tweets
796 Followers
195 Following
Follow People
Catch our Chief Scientific Officer Li Peng on day two of the Festival of Biologics in San Diego. Li will discuss Palleon’s EAGLE platform including safety and proof-of-mechanism data established in the clinic for #cancer treatment.
Learn more: bit.ly/3K38sfn #glycotime
Our Scientific Co-Founder Carolyn Bertozzi presented at #AACR24 during the event's opening plenary session to discuss the creation of new cancer therapies enabled by bioorthogonal chemistry, a field she invented that produced methods of studying #glycobiology . Bioorthogonal…
We celebrate #WorldHealthDay and the many strides made by our industry to improve human health. Our mission is to deliver glycobiology-based medicines to patients and we're proud of the progress we've achieved to advance new treatments for #cancer and #autoimmune diseases. #WHD24
Our Scientific Co-Founder Carolyn Bertozzi recently accepted the 2024 Priestley Medal, the highest honor awarded by the American Chemical Society. Reflecting on her acceptance, she spoke about her early love for chemistry and dedication to research that could lead to groundbreaking…
Our Co-Founder Carolyn Bertozzi will receive the 2024 Priestley Medal - the highest honor awarded by the American Chemical Society! She will discuss her approach to science at a fireside chat next Monday at the ACS Spring Meeting. Register to join virtually: bit.ly/49ScmC6
If you’re eager to explore new approaches to drug development we encourage you to visit our Education Hub to learn more about #glycobiology - the science behind the sugars that coat our cells - and how they play a role in immune modulation: bit.ly/46YJUgT #glycotime
On #InternationalWomensDay we celebrate the many talented women on our team who are committed to #science , #patients and harnessing our unique approach to advancing medicine for #cancer and #autoimmune diseases.
Thank you for paving the way to an entirely new field of drug…
Sialoglycans are crucial to our glycan editing approach. Research suggests that when immune and tumor cells are heavily populated with sialoglycans, also known as hypersialylation, immune evasion can occur.
Learn more: bit.ly/3DUGdvt #glycotime
At Palleon we have the best team – we’re a group of #glycobiology enthusiasts passionate about delivering a new, rapidly evolving field of #medicine to patients.
On #EmployeeAppreciationDay we thank our team for their dedication to advancing potentially transformative science.
Our CEO and Founder Jim Broderick was featured on WuXi AppTec’s BOLD Webinar Series with other innovators around the globe to discuss his role at the forefront of glycobiology drug development.
Check out Jim's insights here: bit.ly/3SsWrUz #biotech #TakingBOLDAction
Congratulations to our Scientific Co-Founder Carolyn Bertozzi for being elected to the 2024 class of the National Academy of Engineering for leveraging bioorthogonal chemistry to engineer tools for drug development. #glycotime More on this honor: stanford.io/3HYQDvS
We understand the vital role cell surface glycans play in regulating the immune response and how these structures can be edited to better treat #cancer and #autoimmunedisease .
Learn more about our glycan editing approach: bit.ly/3DUGdvt #glycotime
To start the year, we came together as a team to celebrate the beginning of yet another year of collective determination to advance what’s possible in #glycobiology . We may be a serious crew when it comes to science, but we also know how to have fun! It was an evening of great…
ICYMI – While visiting Palleon Carolyn Bertozzi spoke to Brad Loncar for BiotechTV. Dr. Bertozzi explains how the sugars, or glycans, that coat cell surfaces play a role in immune modulation and can be manipulated to treat disease.
Watch here: bit.ly/3ZYX6PP…